Effect | None |
Trial Design | Double blind |
Trial Length | 1-6 months |
Number of Subjects | 31 |
Sex | Female |
Age Range | 18-29, 30-44 |
Body Types | Average |
Oral supplementation of 80mg Promensil for three menstrual cycles in otherwise healthy women failed to significantly alter any biomarker of glucose or lipid metabolism measured despite urinary isoflavones increasing 15-fold.